Robert Charles  Peterson net worth and biography

Robert Peterson Biography and Net Worth

CFO of biote

Bob Peterson brings to Biote 25 years of domestic and international finance, accounting, and operational experience across several industries – most notably Pharmaceuticals, Medical Device, and Financial Services. Bob has extensive experience in high growth businesses; as CFO, he has managed not only the traditional finance and accounting functions but also has been instrumental in leading commercial teams, data analytics, operational effectiveness programs, and supply chain activities.

Bob served as the Executive Vice President and Chief Financial Officer of Virbac Corporation, as subsidiary of Virbac S.A., a global Veterinary Pharmaceutical and Wellness company. Bob spent eight years at Alcon Labs/Novartis Eye Care, where he held roles of progressive responsibility including Global Head of Business Planning and Analysis as well as roles in Investor Relations.

Bob seeks to further Biote’s goals to become the leading provider of evidenced-based therapeutic wellness solutions by driving financial and operational excellence while providing strategic leadership and direction. His focus on financial planning and analysis, data analytics, and profitable growth will support Biote’s mission.

Bob holds a Bachelor of Business Administration in Finance and a Masters of Business Administration, both from Texas Christian University, Neeley School of Business.

What is Robert Charles Peterson's net worth?

The estimated net worth of Robert Charles Peterson is at least $84.49 thousand as of July 9th, 2024. Mr. Peterson owns 32,874 shares of biote stock worth more than $84,486 as of December 5th. This net worth estimate does not reflect any other investments that Mr. Peterson may own. Learn More about Robert Charles Peterson's net worth.

How old is Robert Charles Peterson?

Mr. Peterson is currently 47 years old. There are 7 older executives and no younger executives at biote. The oldest executive at biote is Ms. Teresa S. Weber, CEO & Director, who is 71 years old. Learn More on Robert Charles Peterson's age.

How do I contact Robert Charles Peterson?

The corporate mailing address for Mr. Peterson and other biote executives is 501 MADISON AVENUE 12TH FLOOR, NEW YORK NY, 10022. biote can also be reached via phone at 844-604-1246 and via email at [email protected]. Learn More on Robert Charles Peterson's contact information.

Has Robert Charles Peterson been buying or selling shares of biote?

Robert Charles Peterson has not been actively trading shares of biote during the last ninety days. Most recently, Robert Charles Peterson sold 11,376 shares of the business's stock in a transaction on Tuesday, July 9th. The shares were sold at an average price of $7.57, for a transaction totalling $86,116.32. Following the completion of the sale, the chief financial officer now directly owns 32,874 shares of the company's stock, valued at $248,856.18. Learn More on Robert Charles Peterson's trading history.

Who are biote's active insiders?

biote's insider roster includes Stephen Cone (Director), and Robert Peterson (CFO). Learn More on biote's active insiders.

Are insiders buying or selling shares of biote?

In the last twelve months, biote insiders bought shares 11 times. They purchased a total of 1,412,080 shares worth more than $4,598,190.23. The most recent insider tranaction occured on May, 6th when Major Shareholder Guines Llc bought 436,037 shares worth more than $1,421,480.62. Insiders at biote own 24.0% of the company. Learn More about insider trades at biote.

Information on this page was last updated on 5/6/2025.

Robert Charles Peterson Insider Trading History at biote

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/9/2024Sell11,376$7.57$86,116.3232,874View SEC Filing Icon  
See Full Table

Robert Charles Peterson Buying and Selling Activity at biote

This chart shows Robert Charles Peterson's buying and selling at biote by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

biote Company Overview

biote logo
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Read More

Today's Range

Now: $2.57
Low: $2.51
High: $2.60

50 Day Range

MA: $2.76
Low: $2.39
High: $3.19

2 Week Range

Now: $2.57
Low: $2.32
High: $6.90

Volume

38,858 shs

Average Volume

139,889 shs

Market Capitalization

$117.35 million

P/E Ratio

3.25

Dividend Yield

N/A

Beta

1.15